The scale of diagnostic delay in endometriosis is staggering. An estimated 190 million women worldwide live with the condition, yet most wait an average of eight years before receiving confirmed diagnosis. This prolonged diagnostic journey leaves patients suffering without appropriate treatment, managing severe symptoms with inadequate medical support.
New blood-based biomarker testing offers hope. Recent research demonstrates these tests achieve 85% diagnostic accuracy without requiring invasive surgery, potentially accelerating diagnosis by years. For a condition affecting one in ten reproductive-age women, this represents a critical advancement in equitable healthcare delivery.
The geographical prevalence varies significantly, with Europe reporting the highest rates at 11.2%, followed by North America at 10.8%. Early adoption of blood test diagnostics could dramatically reduce suffering across all regions and establish a new standard for non-invasive reproductive medicine. Read the full article on GMJ Newsroom.
Was this article helpful?
